Načítá se...

Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin.

Azithromycin and spiramycin markedly inhibited the growth of Toxoplasma gondii in cultured human fibroblasts. However, 3 days of treatment were required to reveal their full antitoxoplasma activity. This delayed onset of inhibition was similar to that previously reported for clindamycin. Mutants of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Pfefferkorn, E R, Borotz, S E
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology (ASM) 1994
Témata:
On-line přístup:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284392/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8141576/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.1.31
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!